Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the University of Pittsburgh School of Medicine can detect small amounts of the ...

Study suggests belly fat is a midlife indicator of Alzheimer’s disease Learn about the research on belly fat’s impact on ...

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research from Mass General Brigham and ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

The sabotage of cellular messaging, triggered by the formation of chronic stress granules in the brain, may be a key factor ...